Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy (Q40694268)

22 September 2017

title

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy (English)

1 reference

22 September 2017

1 reference

H Link

1

1 reference

22 September 2017

G Maschmeyer

2

1 reference

22 September 2017

P Meyer

3

1 reference

22 September 2017

W Hiddemann

4

1 reference

22 September 2017

W Stille

5

1 reference

22 September 2017

M Helmerking

6

1 reference

22 September 2017

D Adam

7

1 reference

22 September 2017

publication date

1 November 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

69

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

231-243

1 reference

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Septicaemia due to Gram-positive cocci in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Therapy of Murine Aspergillosis with Amphotericin B in Combination with Rifampin or 5-Fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Empiric treatment of localized infections in the febrile neutropenic patient with monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

NIH conference. Respiratory disease in the immunosuppressed patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Amphotericin B: delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01700277

Anorectal Infections in Patients with Malignant Diseases

21 January 2018

1 reference

12 December 2020

Gram-positive bacteraemia in granulocytopenic cancer patients

1 reference

12 December 2020

Aztreonam therapy in neutropenic patients with cancer

1 reference

12 December 2020

Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients

1 reference

12 December 2020

Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study

1 reference

12 December 2020

A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma

1 reference

12 December 2020

Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation

1 reference

12 December 2020

Potential sites of infection that develop in febrile neutropenic patients

1 reference

12 December 2020

A Comparison of Imipenem to Ceftazidime With or Without Amikacin as Empiric Therapy in Febrile Neutropenic Patients

1 reference

12 December 2020

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

12 December 2020

Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Canc

1 reference

12 December 2020

Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications

1 reference

12 December 2020

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

12 December 2020

A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer

1 reference

12 December 2020

Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients

1 reference

12 December 2020

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

12 December 2020

Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial

1 reference

12 December 2020

Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use.

1 reference

12 December 2020

Causes of initial remission induction failure in acute myelogenous leukemia.

1 reference

12 December 2020

Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient

1 reference

12 December 2020

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

12 December 2020

Antifungal treatment strategy in leukemia patients

1 reference

12 December 2020

Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy

1 reference

12 December 2020

A comparison of double beta-lactam combinations with netilmicin/ureidopenicillin regimens in the empirical therapy of febrile neutropenic patients

1 reference

12 December 2020

Treatment of systemic fungal infections with liposomal amphotericin B.

1 reference

12 December 2020

Interaction of Rifampin with Other Antifungal Agents in Experimental Murine Candidiasis

1 reference

12 December 2020

Fungal infections in patients with acute leukemia

1 reference

12 December 2020

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

12 December 2020

Opportunistic fungal infections in patients with neoplastic disease

1 reference

12 December 2020

Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital

1 reference

12 December 2020

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

12 December 2020

Antifungal Action of Rifampin

1 reference

12 December 2020

Bacteremia and fungemia in patients with neoplastic disease

1 reference

12 December 2020

Neutropenia, fever, and infection

1 reference

12 December 2020

Polymicrobial septicemia in the cancer patient

1 reference

12 December 2020

An autopsy study of 1206 acute and chronic leukemias (1958 to 1982)

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

1 reference

12 December 2020

Imipenem/cilastatin as initial therapy for febrile neutropenic patients

1 reference

12 December 2020

A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

1 reference

12 December 2020

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

1 reference

12 December 2020

Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia

1 reference

12 December 2020

Imipenem/cilastatin as secondary therapy for infections in cancer patients

1 reference

12 December 2020

Empiric amphotericin B therapy in patients with acute leukemia

1 reference

12 December 2020

Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy

1 reference

12 December 2020

Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study

1 reference

12 December 2020

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

12 December 2020

Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01700277

1 reference

22 September 2017

1 reference